SCHEMBL6534700

SCHEMBL6534700

CNc1ccccc1S(=O)(=O)c1cc(Cl)ccc1OC

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.61
NPC1 O15118 1/20 0.61
WDR5 P61964 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.49
HTR6 P50406 1/20 0.49
ALDH1A1 P00352 3/20 0.47
POLB P06746 2/20 0.47
KDM4E B2RXH2 1/20 0.47
HPGD P15428 1/20 0.47
RAB9A P51151 1/20 0.47
ALPL P05186 2/20 0.46
CPT1A P50416 1/20 0.46
KAT6A Q92794 1/20 0.46
KMT2A Q03164 2/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
TP53 P04637 1/20 0.45
MEN1 O00255 1/20 0.45
PTGES2 Q9H7Z7 3/20 0.45
USP2 O75604 1/20 0.44
TRPV4 Q9HBA0 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6535042 0.89 TRPV4 (0.55) TSHRNPC1WDR5L3MBTL1HTR6
SCHEMBL7594909 0.78 NPC1 (0.89) TSHRNPC1WDR5L3MBTL1ALDH1A1
SCHEMBL11840111 0.76 HTR6 (0.77) L3MBTL1HTR6ALDH1A1POLBKDM4E
SCHEMBL7572911 0.76 NPC1 (1.00) TSHRNPC1WDR5L3MBTL1ALDH1A1
SCHEMBL6534728 0.74 HTR6 (0.44) TSHRNPC1HTR6ALDH1A1KDM4E
SCHEMBL6832226 0.74 L3MBTL1 (0.68) TSHRNPC1WDR5L3MBTL1ALDH1A1
SCHEMBL6534858 0.74 HTR6 (0.62) TSHRL3MBTL1HTR6ALDH1A1PTGES2
SCHEMBL11514307 0.73 L3MBTL1 (0.66) TSHRNPC1WDR5L3MBTL1ALDH1A1
SCHEMBL11514317 0.73 L3MBTL1 (0.66) TSHRNPC1WDR5L3MBTL1ALDH1A1
SCHEMBL750886 0.72 TRPV4 (0.73) TSHRNPC1WDR5L3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1011652-A4 NOVEL DIARYLSULFONE NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS UNIV THE SCIENCES IN PHILADELP (US) 2004-12-22 EP disclosed
US-6303630-B1 TREATING HUMAN IMMUNODEFICIENCY VIRUS INFECTION BYADMINISTERING TO A HUMAN DIARYLSULFONE COMPOUND UNIVERSITY OF THE SCIENCES IN PHILADELPHIA 2001-10-16 US disclosed
EP-1011652-A1 NOVEL DIARYLSULFONE NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS University of the Sciences in Philadelphia (US) 2000-06-28 EP disclosed
US-6063790-A TREATMENT OF AIDS UNIVERSITY OF THE SCIENCES IN PHILADELPHIA (US) 2000-05-16 US disclosed
WO-1999006037-A1 NOVEL DIARYLSULFONE NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS UNIVERSITY OF THE SCIENCES IN PHILADELPHIA (US) 1999-02-11 WO disclosed